Otezla (apremilast)
Targeted Conditions
Off-Label Usage
(Off-label usage should be carefully evaluated by a dermatologist or rheumatologist.)
Drug Classification Overview
Otezla is a selective phosphodiesterase 4 (PDE4) inhibitor.
It works by modulating intracellular inflammatory pathways, reducing the production of pro-inflammatory cytokines involved in psoriasis and psoriatic arthritis.
Manufacturer in the USA, Mexico, and Canada
USA: Amgen Inc.
Mexico: Amgen México S.A. de C.V.
Canada: Amgen Canada Inc.
Available Strengths and Dosage Forms – United States, Mexico, and Canada
Country Comparison – United States vs Mexico and Canada
Average Retail Price (Monthly Treatment)
Canada: Patients may save approximately 40–60% vs U.S. retail
Mexico: Patients may save approximately 35–55% vs U.S. retail
Savings vary depending on prescription requirements and local availability.
Where to Buy USA
Availability may vary depending on insurance coverage and pharmacy network.
Storage Requirements
Key Benefits
Shipping from Canada
This medication is accessed through fully licensed Canadian pharmacies regulated by Health Canada. All pharmacies included in the MedicalMex network undergo a rigorous review and verification process to ensure compliance with national standards, patient safety, and medication authenticity.
MedicalMex facilitates:
You are working directly with MedicalMex Inc., a U.S.-based company that helps eligible patients safely access affordable medications from Canada — with compliance and concierge support at every step.
Buying from Mexico
This medication is also available through certified pharmacies in Mexico regulated by COFEPRIS. All partners in the MedicalMex network undergo rigorous certification before being approved for patient access.
MedicalMex facilitates:
You are working directly with MedicalMex Inc., a U.S.-based company that manages every detail — from logistics and prescription compliance to patient support — providing secure, affordable access to medications from Mexico.
Side Effects
Patients should notify their healthcare provider if they experience new or worsening mood changes or severe gastrointestinal symptoms.
Warnings and Precautions
Alternative Medications (by Indication)
Biologics: Adalimumab (Humira), Ustekinumab (Stelara), Secukinumab (Cosentyx), Ixekizumab (Taltz)
Traditional systemic therapies: Methotrexate, Cyclosporine, Acitretin
